The New Future of US Telehealth: Lasting Impacts of COVID-19

Ilya Trakhtenberg

future of US telehealth

COVID-19 expands use of telehealth

telehealth use cases

telehealth software ecosystem

eliminating telehealth barriers

COVID-19 and telehealth use cases

increased utilization of telehealth

hospital systems increase telehealth usage

virtual care and asynchronous visits biggest increases

structural and behavioral changes increase telehealth usage

patient and provider forced trial increase telehealth

waived regulatory and reimbursement restrictions with telehealth

forced trial to be lasting impact of COVID-19

telehealth expansion positive impacts and potential risks

telehealth evolution market

telehealth impact to payers and stakeholders

amazon and telehealth

For more information, please visit L.E.K.’s COVID-19 Insights Center or fill out this form to get in touch with us.

Related Insights

Strategy

Presentations

Global Situation Report Insights Edition 1

May 27, 2020

The L.E.K. Global Situation Report is a uniquely rich, current, and customisable collection of indicators that provide a powerful recovery planning aide.

Life Sciences & Pharma

Presentations

COVID-19 Therapeutic Research and Development Landscape

June 3, 2020

The following materials provide a snapshot of the unprecedented scope and speed of biopharma’s therapeutics research and development (R&D) response to…

Healthcare Services

Special Report

Regenerative Medicine Opportunities and Challenges in APAC

October 14, 2020

Regenerative medicine (RM) is challenging the current practice of medicine by treating the root causes of disease and disorders — making it an incredibly…

Organization & Performance

Executive Insights

Back to Work? Post-COVID-19 Remote Working Approaches Reveal the Adoption of Some…

September 18, 2020

As both employers and employees are increasingly encouraged to “go back to work”, early evidence indicates a wide range of post-COVID-19 flexible and…

Life Sciences & Pharma

Executive Insights

CAR-T: Unlocking Barriers to Adoption in Europe

June 23, 2020

L.E.K. Consulting reviews progress to date, outlines barriers to uptake and identifies potential catalysts for accelerating European CAR-T adoption.

Life Sciences & Pharma

Presentations

European Disease Progression Monitor: Edition 8

June 17, 2020

In light of new data surrounding the impact of COVID-19 on the population, health services, pharmaceutical industry and wider economy, L.E.K.’s Healthcare…